TradingKey

關於 Integra Lifesciences Holdings Corp 公司

Integra LifeSciences Holdings Corporation 是一家全球醫療技術公司。該公司通過兩個部門製造和銷售醫療技術和產品：Codman Specialty Surgical (CSS) 和 Tissue Technologies (TT)。CSS 部門包括用於一系列專業的技術和儀器，例如神經外科、神經重症監護和耳鼻喉科。CSS 業務包括一系列品牌，例如 Codman、DuraGen、DuraSeal、CUSA、Mayfield、Bactiseal 和 Certas Plus，用於管理多種疾病狀態，包括腦腫瘤、創傷性腦損傷、腦積水和其他神經系統疾病。該公司提供用於精密、專業和一般外科手術的儀器。TT 部門專注於三個主要領域：複雜傷口手術、外科重建和外周神經修復。TT 部門提供皮膚和傷口修復、骨移植以及神經和肌腱修復產品。

公司簡介

公司代碼IART

公司名稱Integra Lifesciences Holdings Corp

上市日期Aug 16, 1995

CEOMs. Mojdeh Poul

員工數量4396

證券類型Ordinary Share

年結日Aug 16

公司地址1100 Campus Road

城市PRINCETON

上市交易所NASDAQ Global Select Consolidated

國家United States of America

郵編08540

電話16092750500

網址https://www.integralife.com/

公司代碼IART

上市日期Aug 16, 1995

CEOMs. Mojdeh Poul

公司高階主管

名稱

名稱/職務

職務

持股

持股變動

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

1.79M

+1.82%

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+41.78%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+27.45%

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

70.34K

+25.21%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-4.19%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-10.69%

Mr. Harvinder Singh

Executive Vice President, President - International Business

13.25K

+1024.00%

Ms. Mojdeh Poul

President, Chief Executive Officer, Director

--

Ms. Shaundra D. Clay

Independent Director

--

Mr. Chris Ward

IR Contact Officer

--

名稱

名稱/職務

職務

持股

持股變動

Dr. Stuart M. Essig, Ph.D.

Executive Chairman of the Board

1.79M

+1.82%

Mr. Christian S. (Chris) Schade

Independent Director

90.03K

+41.78%

Dr. Keith Bradley, Ph.D.

Independent Director

89.14K

+27.45%

Mr. Michael J. Mcbreen

Executive Vice President, President - Codman Specialty Surgical

70.34K

+25.21%

Ms. Lea Daniels Knight

Chief Financial Officer, Executive Vice President

58.58K

-4.19%

Mr. Jeffrey Mosebrook

Senior Vice President - Finance, Principal Accounting Officer

35.79K

-10.69%

收入明細

單位: USD更新時間: 7月6日週日

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Neurosurgery

190.91M

49.89%

Wound Reconstruction and Care

74.78M

19.54%

Instruments

50.95M

13.31%

ENT

38.80M

10.14%

Private Label

27.21M

7.11%

地區USD

名稱

營收

佔比

United States

282.22M

73.75%

Asia Pacific

45.10M

11.79%

Europe

35.33M

9.23%

Rest of World

20.00M

5.23%

業務

地區

業務USD

名稱

營收

佔比

Neurosurgery

190.91M

49.89%

Wound Reconstruction and Care

74.78M

19.54%

Instruments

50.95M

13.31%

ENT

38.80M

10.14%

Private Label

27.21M

7.11%

股東統計

更新時間: 5月16日週五

持股股東

股東類型

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

12.52%

TRU ST Partnership, L.P.

10.93%

The Vanguard Group, Inc.

9.59%

Rubric Capital Management LP

9.44%

Fuller & Thaler Asset Management Inc.

5.03%

Other

52.49%

持股股東

佔比

BlackRock Institutional Trust Company, N.A.

12.52%

TRU ST Partnership, L.P.

10.93%

The Vanguard Group, Inc.

9.59%

Rubric Capital Management LP

9.44%

Fuller & Thaler Asset Management Inc.

5.03%

Other

52.49%

股東類型

持股股東

佔比

Investment Advisor

41.95%

Investment Advisor/Hedge Fund

39.09%

Hedge Fund

15.00%

Corporation

10.96%

Individual Investor

3.45%

Research Firm

1.90%

Pension Fund

1.10%

Sovereign Wealth Fund

0.62%

Bank and Trust

0.45%

機構持股

更新時間: 7月1日週二

報告期間

機構數

持股數

持股佔比

持股變動

2025Q2

598

89.03M

114.56%

-18.85M

2025Q1

635

87.01M

111.97%

-18.30M

2024Q4

636

81.93M

106.10%

-20.27M

2024Q3

638

82.93M

106.93%

-12.58M

2024Q2

628

84.82M

107.92%

-1.75M

2024Q1

613

79.36M

101.18%

-3.69M

2023Q4

597

79.81M

101.26%

-5.74M

2023Q3

592

81.88M

100.31%

-3.94M

2023Q2

587

82.30M

100.29%

-6.57M

2023Q1

579

85.87M

104.63%

-5.43M

股東持股明細

名稱

持股數

佔比

持股變動

變動比例

公告日期

BlackRock Institutional Trust Company, N.A.

9.75M

12.55%

-341.75K

-3.38%

Mar 31, 2025

TRU ST Partnership, L.P.

8.52M

10.96%

--

Feb 28, 2025

The Vanguard Group, Inc.

7.47M

9.61%

-66.65K

-0.88%

Mar 31, 2025

Rubric Capital Management LP

4.64M

5.98%

+2.03M

+77.35%

Mar 31, 2025

Fuller & Thaler Asset Management Inc.

3.92M

5.05%

-9.76K

-0.25%

Mar 31, 2025

Invesco Advisers, Inc.

3.13M

4.02%

+1.36M

+77.42%

Mar 31, 2025

Wellington Management Company, LLP

2.77M

3.56%

+259.99K

+10.37%

Mar 31, 2025

State Street Global Advisors (US)

2.75M

3.54%

-105.48K

-3.70%

Mar 31, 2025

Boston Management and Research

2.74M

3.53%

--

Mar 31, 2025

AllianceBernstein L.P.

2.71M

3.48%

+128.04K

+4.97%

Mar 31, 2025

持股ETF

更新時間: 8月2日週六

機構名稱

佔比

iShares Neuroscience and Healthcare ETF

1.98%

SPDR S&P Health Care Equipment ETF

1.75%

ROBO Global Healthcare Technology & Innovation ETF

1.08%

Invesco S&P SmallCap Health Care ETF

0.59%

Invesco NASDAQ Future Gen 200 ETF

0.44%

VictoryShares US Small Mid Cap Value Momentum ETF

0.2%

Royce Quant Small-Cap Quality Value ETF

0.15%

iShares S&P Small-Cap 600 Value ETF

0.13%

SPDR S&P 600 Small Cap Value ETF

0.13%

Vanguard US Value Factor ETF

0.12%

iShares Neuroscience and Healthcare ETF

佔比1.98%

SPDR S&P Health Care Equipment ETF

佔比1.75%

ROBO Global Healthcare Technology & Innovation ETF

佔比1.08%

Invesco S&P SmallCap Health Care ETF

佔比0.59%

Invesco NASDAQ Future Gen 200 ETF

佔比0.44%

VictoryShares US Small Mid Cap Value Momentum ETF

佔比0.2%

Royce Quant Small-Cap Quality Value ETF

佔比0.15%

iShares S&P Small-Cap 600 Value ETF

佔比0.13%

SPDR S&P 600 Small Cap Value ETF

佔比0.13%

Vanguard US Value Factor ETF

佔比0.12%

分紅派息

近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股

公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

Integra Lifesciences Holdings Corp

12.560USD

Integra Lifesciences Holdings Corp

12.560

概覽

公司

財務